|
G |
Abcc3 |
ATP-binding cassette, sub-family C member 3 |
decreases expression |
ISO |
Amikacin results in decreased expression of ABCC3 mRNA |
CTD |
PMID:27765674 |
|
NCBI chr11:94,234,121...94,283,843
Ensembl chr11:94,234,121...94,283,823
|
|
G |
Abcc4 |
ATP-binding cassette, sub-family C member 4 |
decreases expression |
ISO |
Amikacin results in decreased expression of ABCC4 mRNA |
CTD |
PMID:27765674 |
|
NCBI chr14:118,720,104...118,945,475
Ensembl chr14:118,720,104...118,943,631
|
|
G |
Casr |
calcium-sensing receptor |
increases activity |
ISO |
Amikacin results in increased activity of CASR protein |
CTD |
PMID:19884751 |
|
NCBI chr16:36,310,947...36,382,605
Ensembl chr16:36,314,058...36,382,503
|
|
G |
Cat |
catalase |
decreases activity multiple interactions |
EXP ISO |
Amikacin results in decreased activity of CAT protein cefepime inhibits the reaction [Amikacin results in decreased activity of CAT protein] |
CTD |
PMID:18781908 PMID:23416261 |
|
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
|
|
G |
Cxcl15 |
C-X-C motif chemokine ligand 15 |
decreases expression |
ISO |
Amikacin results in decreased expression of CXCL8 mRNA |
CTD |
PMID:32816093 |
|
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
|
|
G |
Il1a |
interleukin 1 alpha |
decreases expression |
ISO |
Amikacin results in decreased expression of IL1A mRNA |
CTD |
PMID:32816093 |
|
NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892
|
|
G |
Il1b |
interleukin 1 beta |
decreases expression |
ISO |
Amikacin results in decreased expression of IL1B mRNA |
CTD |
PMID:32816093 |
|
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
|
|
G |
Il24 |
interleukin 24 |
decreases expression |
ISO |
Amikacin results in decreased expression of IL24 mRNA |
CTD |
PMID:32816093 |
|
NCBI chr 1:130,809,801...130,815,153
Ensembl chr 1:130,809,811...130,815,191
|
|
G |
Pgd |
phosphogluconate dehydrogenase |
decreases activity |
ISO |
Amikacin results in decreased activity of PGD protein |
CTD |
PMID:15558954 |
|
NCBI chr 4:149,234,448...149,251,162
Ensembl chr 4:149,234,448...149,251,228
|
|
G |
Pid1 |
phosphotyrosine interaction domain containing 1 |
increases expression |
ISO |
Amikacin results in increased expression of PID1 mRNA |
CTD |
PMID:32816093 |
|
NCBI chr 1:84,014,014...84,317,550
Ensembl chr 1:84,014,017...84,341,901
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
decreases expression |
ISO |
Amikacin results in decreased expression of PTGS2 mRNA |
CTD |
PMID:32816093 |
|
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
|
|
G |
Slc7a11 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 11 |
decreases expression |
ISO |
Amikacin results in decreased expression of SLC7A11 mRNA |
CTD |
PMID:32816093 |
|
NCBI chr 3:50,319,385...50,403,947
Ensembl chr 3:49,846,975...50,398,063
|
|
G |
Slpi |
secretory leukocyte peptidase inhibitor |
increases expression |
ISO |
Amikacin results in increased expression of SLPI mRNA |
CTD |
PMID:32816093 |
|
NCBI chr 2:164,195,990...164,231,086
Ensembl chr 2:164,195,990...164,231,015
|
|
G |
Tyr |
tyrosinase |
decreases activity |
ISO |
Amikacin results in decreased activity of TYR protein |
CTD |
PMID:23416261 |
|
NCBI chr 7:87,073,979...87,142,637
Ensembl chr 7:87,073,979...87,142,720
|
|
|
G |
Abca1 |
ATP-binding cassette, sub-family A member 1 |
multiple interactions |
EXP |
[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of ABCA1 mRNA |
CTD |
PMID:36464106 |
|
NCBI chr 4:53,030,789...53,159,988
Ensembl chr 4:53,030,787...53,159,895
|
|
G |
Abcb11 |
ATP-binding cassette, sub-family B member 11 |
multiple interactions |
EXP |
[Cephalothin co-treated with Neomycin] results in increased expression of ABCB11 mRNA; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of ABCB11 mRNA |
CTD |
PMID:24657338 PMID:36464106 |
|
NCBI chr 2:69,068,626...69,172,960
Ensembl chr 2:69,068,626...69,172,958
|
|
G |
Abcb1a |
ATP-binding cassette, sub-family B member 1A |
multiple interactions |
EXP |
[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of ABCB1A mRNA |
CTD |
PMID:36464106 |
|
NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
|
|
G |
Abcc2 |
ATP-binding cassette, sub-family member 2 |
multiple interactions |
EXP |
[Cephalothin co-treated with Neomycin] results in increased expression of ABCC2 mRNA; [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of ABCC2 mRNA]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of ABCC2 mRNA |
CTD |
PMID:24657338 PMID:36464106 |
|
NCBI chr19:43,770,747...43,826,771
Ensembl chr19:43,770,631...43,829,179
|
|
G |
Abcc3 |
ATP-binding cassette, sub-family C member 3 |
multiple interactions |
EXP |
[Cephalothin co-treated with Neomycin] results in increased expression of ABCC3 mRNA; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of ABCC3 mRNA |
CTD |
PMID:24657338 PMID:36464106 |
|
NCBI chr11:94,234,121...94,283,843
Ensembl chr11:94,234,121...94,283,823
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 (Junior blood group) |
multiple interactions |
EXP |
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of ABCG2 mRNA]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of ABCG2 mRNA |
CTD |
PMID:36464106 |
|
NCBI chr 6:58,561,476...58,669,436
Ensembl chr 6:58,561,508...58,672,661
|
|
G |
Abcg5 |
ATP binding cassette subfamily G member 5 |
multiple interactions |
EXP |
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of ABCG5 mRNA]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of ABCG5 mRNA |
CTD |
PMID:36464106 |
|
NCBI chr17:84,965,602...84,990,439
Ensembl chr17:84,965,662...84,990,439
|
|
G |
Acaca |
acetyl-Coenzyme A carboxylase alpha |
multiple interactions |
EXP |
[Vancomycin co-treated with Neomycin co-treated with Metronidazole co-treated with elemicin] results in increased expression of ACACA mRNA |
CTD |
PMID:34979169 |
|
NCBI chr11:84,020,461...84,292,477
Ensembl chr11:84,020,498...84,292,477
|
|
G |
Acat2 |
acetyl-Coenzyme A acetyltransferase 2 |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ACAT2 protein |
CTD |
PMID:30545405 |
|
NCBI chr17:13,161,929...13,179,612
Ensembl chr17:13,161,777...13,179,634
|
|
G |
Ace2 |
angiotensin converting enzyme 2 |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ACE2 protein |
CTD |
PMID:30545405 |
|
NCBI chr X:162,922,338...162,971,414
Ensembl chr X:162,922,328...162,971,416
|
|
G |
Ada |
adenosine deaminase |
decreases activity multiple interactions |
EXP |
Neomycin results in decreased activity of ADA protein Tetrachlorodibenzodioxin inhibits the reaction [Neomycin results in decreased activity of ADA protein] |
CTD |
PMID:7853360 |
|
NCBI chr 2:163,565,703...163,592,154
Ensembl chr 2:163,568,504...163,592,159
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
multiple interactions |
EXP |
[Vancomycin co-treated with Neomycin co-treated with Metronidazole co-treated with elemicin] results in increased expression of ADIPOQ mRNA |
CTD |
PMID:34979169 |
|
NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
|
|
G |
Ahsg |
alpha-2-HS-glycoprotein |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of AHSG protein |
CTD |
PMID:30545405 |
|
NCBI chr16:22,710,793...22,718,193
Ensembl chr16:22,710,027...22,718,199
|
|
G |
Aldob |
aldolase B, fructose-bisphosphate |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ALDOB protein |
CTD |
PMID:30545405 |
|
NCBI chr 4:49,535,993...49,549,546
Ensembl chr 4:49,535,995...49,549,546
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
multiple interactions increases expression |
EXP |
peoniflorin inhibits the reaction [Neomycin results in increased expression of APAF1 mRNA] |
CTD |
PMID:29292089 |
|
NCBI chr10:90,825,173...90,918,688
Ensembl chr10:90,825,173...90,918,632
|
|
G |
Arg2 |
arginase type II |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of ARG2 protein |
CTD |
PMID:30545405 |
|
NCBI chr12:79,177,562...79,203,075
Ensembl chr12:79,177,551...79,203,075
|
|
G |
Arpc3 |
actin related protein 2/3 complex, subunit 3 |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ARPC3 protein |
CTD |
PMID:30545405 |
|
NCBI chr 5:122,529,941...122,544,244
Ensembl chr 5:122,529,941...122,552,247
|
|
G |
Asah1 |
N-acylsphingosine amidohydrolase 1 |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of ASAH1 protein |
CTD |
PMID:30545405 |
|
NCBI chr 8:41,793,683...41,850,681
Ensembl chr 8:41,793,234...41,827,810
|
|
G |
Atp1a1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ATP1A1 protein |
CTD |
PMID:30545405 |
|
NCBI chr 3:101,483,535...101,512,023
Ensembl chr 3:101,483,535...101,512,000
|
|
G |
Atp2a3 |
ATPase, Ca++ transporting, ubiquitous |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ATP2A3 protein |
CTD |
PMID:30545405 |
|
NCBI chr11:72,851,995...72,883,869
Ensembl chr11:72,851,995...72,883,870
|
|
G |
Atp5mf |
ATP synthase membrane subunit f |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ATP5MF protein |
CTD |
PMID:30545405 |
|
NCBI chr 5:145,120,514...145,128,351
Ensembl chr 5:145,120,508...145,128,872
|
|
G |
Atp5pd |
ATP synthase peripheral stalk subunit d |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ATP5PD protein |
CTD |
PMID:30545405 |
|
NCBI chr11:115,306,517...115,310,775
Ensembl chr11:115,306,515...115,310,788
|
|
G |
Atp5pf |
ATP synthase peripheral stalk subunit F6 |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ATP5PF protein |
CTD |
PMID:30545405 |
|
NCBI chr16:84,624,754...84,632,495
Ensembl chr16:84,624,754...84,632,513
|
|
G |
B3galt5 |
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of B3GALT5 protein |
CTD |
PMID:30545405 |
|
NCBI chr16:96,037,001...96,121,059
Ensembl chr16:96,037,001...96,121,059
|
|
G |
Bax |
BCL2-associated X protein |
increases expression multiple interactions |
EXP |
Neomycin results in increased expression of BAX mRNA peoniflorin inhibits the reaction [Neomycin results in increased expression of BAX mRNA] |
CTD |
PMID:29292089 |
|
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
|
|
G |
Bcat1 |
branched chain aminotransferase 1, cytosolic |
decreases expression |
EXP |
Neomycin results in decreased expression of BCAT1 mRNA |
CTD |
PMID:30626089 |
|
NCBI chr 6:144,939,561...145,021,883
Ensembl chr 6:144,939,561...145,021,910
|
|
G |
Bcl2 |
B cell leukemia/lymphoma 2 |
multiple interactions decreases expression |
EXP |
peoniflorin inhibits the reaction [Neomycin results in decreased expression of BCL2 mRNA]; peoniflorin inhibits the reaction [Neomycin results in decreased expression of BCL2 protein] Neomycin results in decreased expression of BCL2 mRNA; Neomycin results in decreased expression of BCL2 protein |
CTD |
PMID:29292089 |
|
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
|
|
G |
Casp3 |
caspase 3 |
multiple interactions affects cleavage increases expression |
EXP |
BIX 01294 affects the reaction [Neomycin affects the cleavage of CASP3 protein]; peoniflorin inhibits the reaction [Neomycin results in increased expression of CASP3 mRNA]; peoniflorin inhibits the reaction [Neomycin results in increased expression of CASP3 protein modified form] Neomycin results in increased expression of CASP3 mRNA; Neomycin results in increased expression of CASP3 protein modified form |
CTD |
PMID:23429292 PMID:29292089 |
|
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
|
|
G |
Casp9 |
caspase 9 |
multiple interactions increases expression |
EXP |
peoniflorin inhibits the reaction [Neomycin results in increased expression of CASP9 mRNA]; peoniflorin inhibits the reaction [Neomycin results in increased expression of CASP9 protein modified form] Neomycin results in increased expression of CASP9 mRNA; Neomycin results in increased expression of CASP9 protein modified form |
CTD |
PMID:29292089 |
|
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
|
|
G |
Casr |
calcium-sensing receptor |
multiple interactions |
ISO |
CASR protein promotes the reaction [Neomycin results in increased phosphorylation of and results in increased activity of MAPK1 protein]; CASR protein promotes the reaction [Neomycin results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Neomycin binds to and results in increased activity of CASR protein [Neomycin binds to and results in increased activity of CASR protein] which results in increased abundance of Calcium; [Neomycin binds to and results in increased activity of CASR protein] which results in increased abundance of Inositol Phosphates; Neomycin binds to and results in increased activity of CASR protein |
CTD |
PMID:10231437 PMID:17537980 |
|
NCBI chr16:36,310,947...36,382,605
Ensembl chr16:36,314,058...36,382,503
|
|
G |
Ccng2 |
cyclin G2 |
increases expression |
EXP |
Neomycin results in increased expression of CCNG2 mRNA |
CTD |
PMID:30626089 |
|
NCBI chr 5:93,415,432...93,424,090
Ensembl chr 5:93,415,116...93,424,090
|
|
G |
Cd86 |
CD86 antigen |
increases expression |
ISO |
Neomycin results in increased expression of CD86 protein |
CTD |
PMID:19665512 |
|
NCBI chr16:36,389,318...36,486,439
Ensembl chr16:36,424,231...36,486,443
|
|
G |
Cdh1 |
cadherin 1 |
decreases expression |
EXP |
Neomycin results in decreased expression of CDH1 protein |
CTD |
PMID:15953529 |
|
NCBI chr 8:107,329,982...107,396,879
Ensembl chr 8:107,329,983...107,396,878
|
|
G |
Clca4a |
chloride channel accessory 4A |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of CLCA4 protein |
CTD |
PMID:30545405 |
|
NCBI chr 3:144,658,247...144,680,806
Ensembl chr 3:144,658,241...144,680,806
|
|
G |
Cldn5 |
claudin 5 |
multiple interactions |
EXP |
[Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of CLDN5 mRNA]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of CLDN5 protein] |
CTD |
PMID:35390362 |
|
NCBI chr16:18,595,597...18,597,012
Ensembl chr16:18,595,597...18,597,012
|
|
G |
Cldn7 |
claudin 7 |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of CLDN7 protein |
CTD |
PMID:30545405 |
|
NCBI chr11:69,855,605...69,858,712
Ensembl chr11:69,855,605...69,858,711
|
|
G |
Cmbl |
carboxymethylenebutenolidase homolog |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CMBL protein |
CTD |
PMID:30545405 |
|
NCBI chr15:31,565,314...31,590,266
Ensembl chr15:31,565,535...31,590,265
|
|
G |
Cndp2 |
CNDP dipeptidase 2 |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of CNDP2 protein |
CTD |
PMID:30545405 |
|
NCBI chr18:84,685,590...84,703,827
Ensembl chr18:84,685,590...84,703,827
|
|
G |
Cox5a |
cytochrome c oxidase subunit 5A |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of COX5A protein |
CTD |
PMID:30545405 |
|
NCBI chr 9:57,423,012...57,439,710
Ensembl chr 9:57,428,557...57,439,709
|
|
G |
Cox6b1 |
cytochrome c oxidase, subunit 6B1 |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of COX6B1 protein |
CTD |
PMID:30545405 |
|
NCBI chr 7:30,316,396...30,325,539
Ensembl chr 7:30,316,286...30,325,576
|
|
G |
Cox7a2 |
cytochrome c oxidase subunit 7A2 |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of COX7A2 protein |
CTD |
PMID:30545405 |
|
NCBI chr 9:79,662,523...79,667,135
Ensembl chr 9:79,662,643...79,667,160
|
|
G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
multiple interactions |
EXP |
[Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] inhibits the reaction [Dextran Sulfate results in increased expression of CSF2 protein]; [Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] results in decreased expression of CSF2 protein |
CTD |
PMID:31442584 |
|
NCBI chr11:54,138,096...54,140,725
Ensembl chr11:54,138,097...54,140,493
|
|
G |
Cth |
cystathionine gamma lyase |
multiple interactions decreases expression |
EXP |
Plant Oils inhibits the reaction [Neomycin results in decreased expression of CTH mRNA] |
CTD |
PMID:30626089 |
|
NCBI chr 3:157,599,885...157,630,718
Ensembl chr 3:157,599,885...157,630,714
|
|
G |
Ctsa |
cathepsin A |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CTSA protein |
CTD |
PMID:30545405 |
|
NCBI chr 2:164,674,792...164,682,952
Ensembl chr 2:164,674,793...164,682,952
|
|
G |
Cxcl9 |
C-X-C motif chemokine ligand 9 |
multiple interactions |
EXP |
[Vancomycin co-treated with Neomycin co-treated with Cilastatin, Imipenem Drug Combination] inhibits the reaction [Doxorubicin results in increased expression of CXCL9 mRNA]; [Vancomycin co-treated with Neomycin co-treated with Cilastatin, Imipenem Drug Combination] inhibits the reaction [Nanotubes, Carbon promotes the reaction [Doxorubicin results in increased expression of CXCL9 mRNA]] |
CTD |
PMID:32068018 |
|
NCBI chr 5:92,469,190...92,475,938
Ensembl chr 5:92,469,206...92,475,938
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CYP1A2 mRNA |
CTD |
PMID:30545405 |
|
NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986
|
|
G |
Cyp27a1 |
cytochrome P450, family 27, subfamily a, polypeptide 1 |
multiple interactions |
EXP |
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP27A1 mRNA]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP27A1 mRNA |
CTD |
PMID:36464106 |
|
NCBI chr 1:74,752,311...74,777,056
Ensembl chr 1:74,752,733...74,777,051
|
|
G |
Cyp2c52-ps |
cytochrome P450, family 2, subfamily c, polypeptide 52, pseudogene |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CYP2C11 mRNA |
CTD |
PMID:30545405 |
|
NCBI chr19:38,965,106...38,992,071
Ensembl chr19:38,965,091...38,991,733
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CYP2E1 mRNA |
CTD |
PMID:30545405 |
|
NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
|
|
G |
Cyp7a1 |
cytochrome P450, family 7, subfamily a, polypeptide 1 |
multiple interactions |
EXP |
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP7A1 mRNA]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP7A1 mRNA |
CTD |
PMID:36464106 |
|
NCBI chr 4:6,265,612...6,275,632
Ensembl chr 4:6,265,612...6,275,633
|
|
G |
Cyp7b1 |
cytochrome P450, family 7, subfamily b, polypeptide 1 |
multiple interactions |
EXP |
[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP7B1 mRNA |
CTD |
PMID:36464106 |
|
NCBI chr 3:18,126,108...18,298,054
Ensembl chr 3:18,126,114...18,297,502
|
|
G |
Cyp8b1 |
cytochrome P450, family 8, subfamily b, polypeptide 1 |
multiple interactions |
EXP |
[Cephalothin co-treated with Neomycin] results in decreased expression of CYP8B1 mRNA; [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP8B1 mRNA]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP8B1 mRNA |
CTD |
PMID:24657338 PMID:36464106 |
|
NCBI chr 9:121,743,422...121,745,371
Ensembl chr 9:121,743,422...121,745,371
|
|
G |
Epcam |
epithelial cell adhesion molecule |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of EPCAM protein |
CTD |
PMID:30545405 |
|
NCBI chr17:87,943,407...87,958,555
Ensembl chr17:87,943,407...87,958,557
|
|
G |
Etfa |
electron transferring flavoprotein, alpha polypeptide |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ETFA protein |
CTD |
PMID:30545405 |
|
NCBI chr 9:55,361,720...55,419,528
Ensembl chr 9:55,361,792...55,419,527
|
|
G |
Ezr |
ezrin |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of EZR protein |
CTD |
PMID:30545405 |
|
NCBI chr17:7,005,530...7,050,179
Ensembl chr17:7,005,440...7,050,183
|
|
G |
Fasn |
fatty acid synthase |
multiple interactions |
EXP |
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of FASN mRNA]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of FASN mRNA; [Vancomycin co-treated with Neomycin co-treated with Metronidazole] inhibits the reaction [elemicin results in increased expression of FASN mRNA] |
CTD |
PMID:34979169 PMID:36464106 |
|
NCBI chr11:120,696,784...120,715,992
Ensembl chr11:120,696,672...120,715,373
|
|
G |
Fgf15 |
fibroblast growth factor 15 |
multiple interactions |
EXP |
[Cephalothin co-treated with Neomycin] results in increased expression of FGF15 mRNA |
CTD |
PMID:24657338 |
|
NCBI chr 7:144,450,269...144,454,690
Ensembl chr 7:144,450,268...144,454,690
|
|
G |
Foxo1 |
forkhead box O1 |
multiple interactions increases expression |
EXP |
Plant Oils inhibits the reaction [Neomycin results in increased expression of FOXO1 mRNA] |
CTD |
PMID:30626089 |
|
NCBI chr 3:52,175,758...52,257,530
Ensembl chr 3:52,175,757...52,260,642
|
|
G |
Gadd45g |
growth arrest and DNA-damage-inducible 45 gamma |
increases expression multiple interactions |
EXP |
Neomycin results in increased expression of GADD45G mRNA Plant Oils inhibits the reaction [Neomycin results in increased expression of GADD45G mRNA] |
CTD |
PMID:30626089 |
|
NCBI chr13:52,000,711...52,002,511
Ensembl chr13:52,000,714...52,002,504
|
|
G |
Gclm |
glutamate-cysteine ligase, modifier subunit |
multiple interactions |
EXP |
[Vancomycin co-treated with Neomycin co-treated with Metronidazole] promotes the reaction [Zinc Oxide analog results in increased expression of GCLM protein] |
CTD |
PMID:36535435 |
|
NCBI chr 3:122,039,206...122,060,864
Ensembl chr 3:122,039,206...122,064,381
|
|
G |
Gfpt2 |
glutamine fructose-6-phosphate transaminase 2 |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of GFPT2 protein |
CTD |
PMID:30545405 |
|
NCBI chr11:49,684,981...49,729,448
Ensembl chr11:49,685,005...49,729,440
|
|
G |
Gipc2 |
GIPC PDZ domain containing family, member 2 |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of GIPC2 protein |
CTD |
PMID:30545405 |
|
NCBI chr 3:151,799,476...151,871,537
Ensembl chr 3:151,799,170...151,871,867
|
|
G |
Gng12 |
guanine nucleotide binding protein (G protein), gamma 12 |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of GNG12 protein |
CTD |
PMID:30545405 |
|
NCBI chr 6:66,873,381...66,998,345
Ensembl chr 6:66,873,381...66,998,334
|
|
G |
Gpt |
glutamic pyruvic transaminase, soluble |
multiple interactions |
EXP |
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased activity of GPT protein]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased activity of GPT protein; [Vancomycin co-treated with Neomycin co-treated with Metronidazole] inhibits the reaction [elemicin results in increased activity of GPT protein] |
CTD |
PMID:34979169 PMID:36464106 |
|
NCBI chr15:76,580,926...76,583,875
Ensembl chr15:76,579,916...76,583,886
|
|
G |
Gpt2 |
glutamic pyruvate transaminase (alanine aminotransferase) 2 |
decreases expression |
EXP |
Neomycin results in decreased expression of GPT2 mRNA |
CTD |
PMID:30626089 |
|
NCBI chr 8:86,219,090...86,255,531
Ensembl chr 8:86,219,205...86,254,189
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of GPX1 protein |
CTD |
PMID:30545405 |
|
NCBI chr 9:108,216,279...108,217,541
Ensembl chr 9:108,216,102...108,217,542
|
|
G |
Gstm2 |
glutathione S-transferase, mu 2 |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of GSTM2 mRNA |
CTD |
PMID:30545405 |
|
NCBI chr 3:107,889,018...107,893,736
Ensembl chr 3:107,889,018...107,893,769
|
|
G |
H2-DMb1 |
histocompatibility 2, class II, locus Mb1 |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of RT1-DMB protein |
CTD |
PMID:30545405 |
|
NCBI chr17:34,372,165...34,379,203
Ensembl chr17:34,372,046...34,379,204
|
|
G |
Hexb |
hexosaminidase B |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of HEXB protein |
CTD |
PMID:30545405 |
|
NCBI chr13:97,312,839...97,334,865
Ensembl chr13:97,312,839...97,334,865
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
multiple interactions |
EXP |
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of HMGCR mRNA]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of HMGCR mRNA |
CTD |
PMID:36464106 |
|
NCBI chr13:96,785,470...96,807,444
Ensembl chr13:96,785,475...96,807,444
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions |
EXP |
[Vancomycin co-treated with Neomycin co-treated with Metronidazole] promotes the reaction [Zinc Oxide analog results in increased expression of HMOX1 protein] |
CTD |
PMID:36535435 |
|
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
|
|
G |
Hnrnph2 |
heterogeneous nuclear ribonucleoprotein H2 |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of HNRNPH2 protein |
CTD |
PMID:30545405 |
|
NCBI chr X:133,501,928...133,507,809
Ensembl chr X:133,501,928...133,507,809
|
|
G |
Hp |
haptoglobin |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of HP protein |
CTD |
PMID:30545405 |
|
NCBI chr 8:110,301,760...110,305,804
Ensembl chr 8:110,301,760...110,305,804
|
|
G |
Hspd1 |
heat shock protein 1 (chaperonin) |
multiple interactions |
ISO |
Neomycin inhibits the reaction [Adenosine Triphosphate results in increased expression of HSPD1 protein] |
CTD |
PMID:16178011 |
|
NCBI chr 1:55,116,992...55,127,402
Ensembl chr 1:55,116,994...55,127,402
|
|
G |
Htr4 |
5 hydroxytryptamine (serotonin) receptor 4 |
multiple interactions |
EXP |
[Vancomycin co-treated with Neomycin co-treated with Metronidazole] promotes the reaction [Zinc Oxide results in increased expression of HTR4 mRNA]; [Vancomycin co-treated with Neomycin co-treated with Metronidazole] results in increased expression of HTR4 mRNA |
CTD |
PMID:36535435 |
|
NCBI chr18:62,456,618...62,636,098
Ensembl chr18:62,457,275...62,629,648
|
|
G |
Il18 |
interleukin 18 |
multiple interactions |
EXP |
[Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased secretion of IL18 protein] |
CTD |
PMID:35390362 |
|
NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
EXP |
[Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of and results in increased secretion of IL1B protein]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of IL1B mRNA]; [Vancomycin co-treated with Neomycin co-treated with Cilastatin, Imipenem Drug Combination] inhibits the reaction [Doxorubicin results in increased expression of IL1B protein]; [Vancomycin co-treated with Neomycin co-treated with Cilastatin, Imipenem Drug Combination] inhibits the reaction [Nanotubes, Carbon promotes the reaction [Doxorubicin results in increased expression of IL1B protein]] |
CTD |
PMID:32068018 PMID:35390362 |
|
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
EXP |
[Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] inhibits the reaction [Dextran Sulfate results in increased expression of IL6 protein]; [Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] results in decreased expression of IL6 protein; Dextran Sulfate inhibits the reaction [[Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] results in decreased expression of IL6 protein] |
CTD |
PMID:31442584 |
|
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
|
|
G |
Inhba |
inhibin beta-A |
increases expression |
EXP |
Neomycin results in increased expression of INHBA mRNA |
CTD |
PMID:30626089 |
|
NCBI chr13:16,178,841...16,206,194
Ensembl chr13:16,186,436...16,206,206
|
|
G |
Ins2 |
insulin II |
multiple interactions |
ISO |
Neomycin inhibits the reaction [INS protein results in increased uptake of cobaltous chloride] |
CTD |
PMID:14622148 |
|
NCBI chr 7:142,232,393...142,233,463
Ensembl chr 7:142,232,393...142,297,118
|
|
G |
Irs2 |
insulin receptor substrate 2 |
increases expression |
EXP |
Neomycin results in increased expression of IRS2 mRNA |
CTD |
PMID:30626089 |
|
NCBI chr 8:11,034,681...11,058,929
Ensembl chr 8:11,034,681...11,058,458
|
|
G |
Jun |
jun proto-oncogene |
multiple interactions increases expression |
ISO |
3,9-bis((ethylthio)methyl)-K-252a inhibits the reaction [Neomycin results in increased expression of JUN protein modified form] |
CTD |
PMID:10627579 |
|
NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459
|
|
G |
Klf2 |
Kruppel-like transcription factor 2 (lung) |
increases expression |
EXP |
Neomycin results in increased expression of KLF2 mRNA |
CTD |
PMID:30626089 |
|
NCBI chr 8:73,072,906...73,075,498
Ensembl chr 8:73,072,877...73,075,500
|
|
G |
Kng2 |
kininogen 2 |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of MAP1 protein |
CTD |
PMID:30545405 |
|
NCBI chr16:22,804,602...22,847,851
Ensembl chr16:22,804,604...22,848,232
|
|
G |
Krt16 |
keratin 16 |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of KRT16 protein |
CTD |
PMID:30545405 |
|
NCBI chr11:100,136,917...100,139,728
Ensembl chr11:100,136,917...100,139,728
|
|
G |
Ldlr |
low density lipoprotein receptor |
multiple interactions |
EXP |
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of LDLR mRNA]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of LDLR mRNA |
CTD |
PMID:36464106 |
|
NCBI chr 9:21,634,872...21,661,215
Ensembl chr 9:21,634,779...21,661,215
|
|
G |
Lep |
leptin |
multiple interactions |
EXP |
[Vancomycin co-treated with Neomycin co-treated with Metronidazole co-treated with elemicin] results in increased expression of LEP mRNA |
CTD |
PMID:34979169 |
|
NCBI chr 6:29,060,220...29,073,875
Ensembl chr 6:29,060,219...29,073,876
|
|
G |
Lpin1 |
lipin 1 |
multiple interactions |
EXP |
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of LPIN1 mRNA]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of LPIN1 mRNA |
CTD |
PMID:36464106 |
|
NCBI chr12:16,585,670...16,697,020
Ensembl chr12:16,585,670...16,696,967
|
|
G |
Lyz2 |
lysozyme 2 |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of LYZ2 protein |
CTD |
PMID:30545405 |
|
NCBI chr10:117,113,446...117,118,177
Ensembl chr10:117,113,236...117,118,226
|
|
G |
Mapk1 |
mitogen-activated protein kinase 1 |
multiple interactions increases expression |
ISO EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Neomycin results in increased phosphorylation of and results in increased activity of MAPK1 protein]; CASR protein promotes the reaction [Neomycin results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Neomycin results in increased phosphorylation of and results in increased activity of MAPK1 protein peoniflorin inhibits the reaction [Neomycin results in increased expression of MAPK1 protein modified form] |
CTD |
PMID:17537980 PMID:29292089 |
|
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
|
|
G |
Mapk3 |
mitogen-activated protein kinase 3 |
multiple interactions increases expression |
ISO EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Neomycin results in increased phosphorylation of and results in increased activity of MAPK3 protein]; CASR protein promotes the reaction [Neomycin results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Neomycin results in increased phosphorylation of and results in increased activity of MAPK3 protein Neomycin results in increased expression of MAPK3 protein modified form peoniflorin inhibits the reaction [Neomycin results in increased expression of MAPK3 protein modified form] [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of MAPK3 protein |
CTD |
PMID:17537980 PMID:29292089 PMID:30545405 |
|
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
|
|
G |
Mlxip |
MLX interacting protein |
multiple interactions |
EXP |
[Vancomycin co-treated with Neomycin co-treated with Metronidazole] inhibits the reaction [elemicin results in increased expression of MLXIP mRNA] |
CTD |
PMID:34979169 |
|
NCBI chr 5:123,532,438...123,595,998
Ensembl chr 5:123,532,861...123,595,995
|
|
G |
Mthfd2 |
methylenetetrahydrofolate dehydrogenase (NAD+ dependent), methenyltetrahydrofolate cyclohydrolase |
decreases expression multiple interactions |
EXP |
Neomycin results in decreased expression of MTHFD2 mRNA Plant Oils inhibits the reaction [Neomycin results in decreased expression of MTHFD2 mRNA] |
CTD |
PMID:30626089 |
|
NCBI chr 6:83,282,686...83,302,926
Ensembl chr 6:83,282,673...83,302,890
|
|
G |
Myd88 |
myeloid differentiation primary response gene 88 |
multiple interactions |
EXP |
[Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of MYD88 mRNA]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of MYD88 protein] |
CTD |
PMID:35390362 |
|
NCBI chr 9:119,165,000...119,169,084
Ensembl chr 9:119,165,000...119,170,477
|
|
G |
Myh14 |
myosin, heavy polypeptide 14 |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of MYH14 protein |
CTD |
PMID:30545405 |
|
NCBI chr 7:44,255,227...44,320,296
Ensembl chr 7:44,255,227...44,320,267
|
|
G |
Ndufa13 |
NADH:ubiquinone oxidoreductase subunit A13 |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of NDUFA13 protein |
CTD |
PMID:30545405 |
|
NCBI chr 8:70,346,813...70,355,208
Ensembl chr 8:70,346,830...70,355,208
|
|
G |
Ndufab1 |
NADH:ubiquinone oxidoreductase subunit AB1 |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of NDUFAB1 protein |
CTD |
PMID:30545405 |
|
NCBI chr 7:121,686,038...121,701,071
Ensembl chr 7:121,684,626...121,701,109
|
|
G |
Nog |
noggin |
increases expression |
EXP |
Neomycin results in increased expression of NOG mRNA |
CTD |
PMID:30626089 |
|
NCBI chr11:89,191,464...89,193,385
Ensembl chr11:89,191,464...89,193,158
|
|
G |
Nos2 |
nitric oxide synthase 2, inducible |
multiple interactions |
EXP |
[Vancomycin co-treated with Neomycin co-treated with Cilastatin, Imipenem Drug Combination] inhibits the reaction [Doxorubicin results in increased expression of NOS2 mRNA]; [Vancomycin co-treated with Neomycin co-treated with Cilastatin, Imipenem Drug Combination] inhibits the reaction [Nanotubes, Carbon promotes the reaction [Doxorubicin results in increased expression of NOS2 mRNA]] |
CTD |
PMID:32068018 |
|
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
|
|
G |
Npc1l1 |
NPC1 like intracellular cholesterol transporter 1 |
multiple interactions |
EXP |
[Cephalothin co-treated with Neomycin] results in increased expression of NPC1L1 mRNA |
CTD |
PMID:24657338 |
|
NCBI chr11:6,161,011...6,180,245
Ensembl chr11:6,161,013...6,180,143
|
|
G |
Npc2 |
NPC intracellular cholesterol transporter 2 |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of NPC2 protein |
CTD |
PMID:30545405 |
|
NCBI chr12:84,801,333...84,819,886
Ensembl chr12:84,801,336...84,819,926
|
|
G |
Nr5a2 |
nuclear receptor subfamily 5, group A, member 2 |
multiple interactions |
EXP |
[Cephalothin co-treated with Neomycin] results in increased expression of NR5A2 mRNA |
CTD |
PMID:24657338 |
|
NCBI chr 1:136,770,300...136,888,186
Ensembl chr 1:136,770,309...136,888,186
|
|
G |
Ocln |
occludin |
multiple interactions |
EXP |
[Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of OCLN mRNA]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of OCLN protein] |
CTD |
PMID:35390362 |
|
NCBI chr13:100,633,012...100,689,226
Ensembl chr13:100,633,015...100,689,226
|
|
G |
Pdxk |
pyridoxal (pyridoxine, vitamin B6) kinase |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of PDXK protein |
CTD |
PMID:30545405 |
|
NCBI chr10:78,272,581...78,300,782
Ensembl chr10:78,272,578...78,300,809
|
|
G |
Pfn1 |
profilin 1 |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of PFN1 protein |
CTD |
PMID:30545405 |
|
NCBI chr11:70,542,670...70,547,625
Ensembl chr11:70,542,676...70,545,470
|
|
G |
Pgam1 |
phosphoglycerate mutase 1 |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of PGAM1 protein |
CTD |
PMID:30545405 |
|
NCBI chr19:41,900,310...41,907,104
Ensembl chr19:41,900,362...41,907,099
|
|
G |
Pmm2 |
phosphomannomutase 2 |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of PMM2 protein |
CTD |
PMID:30545405 |
|
NCBI chr16:8,455,467...8,475,472
Ensembl chr16:8,455,538...8,480,331
|
|
G |
Ppp1ca |
protein phosphatase 1 catalytic subunit alpha |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of PPP1CA protein |
CTD |
PMID:30545405 |
|
NCBI chr19:4,242,173...4,245,418
Ensembl chr19:4,242,064...4,245,419
|
|
G |
Ppp1cb |
protein phosphatase 1 catalytic subunit beta |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of PPP1CB protein |
CTD |
PMID:30545405 |
|
NCBI chr 5:32,616,192...32,651,057
Ensembl chr 5:32,616,187...32,674,777
|
|
G |
Ppp1cc |
protein phosphatase 1 catalytic subunit gamma |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of PPP1CC protein |
CTD |
PMID:30545405 |
|
NCBI chr 5:122,296,338...122,313,336
Ensembl chr 5:122,296,341...122,313,336
|
|
G |
Psat1 |
phosphoserine aminotransferase 1 |
multiple interactions decreases expression |
EXP |
Plant Oils inhibits the reaction [Neomycin results in decreased expression of PSAT1 mRNA] |
CTD |
PMID:30626089 |
|
NCBI chr19:15,882,487...15,902,423
Ensembl chr19:15,882,042...15,924,701
|
|
G |
Psma3 |
proteasome subunit alpha 3 |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of PSMA3 protein |
CTD |
PMID:30545405 |
|
NCBI chr12:71,016,082...71,042,651
Ensembl chr12:71,021,395...71,043,121
|
|
G |
Psph |
phosphoserine phosphatase |
decreases expression multiple interactions |
EXP |
Neomycin results in decreased expression of PSPH mRNA Plant Oils inhibits the reaction [Neomycin results in decreased expression of PSPH mRNA] |
CTD |
PMID:30626089 |
|
NCBI chr 5:129,842,622...129,864,318
Ensembl chr 5:129,842,622...129,864,513
|
|
G |
Ralb |
v-ral simian leukemia viral oncogene B |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of RALB protein |
CTD |
PMID:30545405 |
|
NCBI chr 1:119,398,035...119,432,512
Ensembl chr 1:119,398,035...119,432,524
|
|
G |
Ran |
RAN, member RAS oncogene family |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of RAN protein |
CTD |
PMID:30545405 |
|
NCBI chr 5:129,097,264...129,101,388
Ensembl chr 5:129,097,133...129,101,387
|
|
G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
multiple interactions |
EXP |
[Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of RELA mRNA]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of RELA protein] |
CTD |
PMID:35390362 |
|
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
|
|
G |
Rida |
reactive intermediate imine deaminase A homolog |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of RIDA protein |
CTD |
PMID:30545405 |
|
NCBI chr15:34,484,168...34,495,392
Ensembl chr15:34,484,167...34,495,401
|
|
G |
Rpl30 |
ribosomal protein L30 |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of RPL30 protein |
CTD |
PMID:30545405 |
|
NCBI chr15:34,440,649...34,443,405
Ensembl chr15:34,440,651...34,443,786
|
|
G |
Rpn2 |
ribophorin II |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of RPN2 protein |
CTD |
PMID:30545405 |
|
NCBI chr 2:157,121,018...157,168,238
Ensembl chr 2:157,120,937...157,168,239
|
|
G |
Rps23 |
ribosomal protein S23 |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of RPS23 protein |
CTD |
PMID:30545405 |
|
NCBI chr13:91,071,241...91,072,851
Ensembl chr13:91,071,077...91,073,069
|
|
G |
Rps27l |
ribosomal protein S27-like |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of RPS27L protein |
CTD |
PMID:30545405 |
|
NCBI chr 9:66,851,906...66,856,804
Ensembl chr 9:66,853,368...66,856,798
|
|
G |
Rps6kb1 |
ribosomal protein S6 kinase, polypeptide 1 |
affects phosphorylation |
EXP |
Neomycin affects the phosphorylation of RPS6KB1 protein |
CTD |
PMID:16537399 |
|
NCBI chr11:86,389,695...86,435,711
Ensembl chr11:86,389,697...86,435,631
|
|
G |
S100a10 |
S100 calcium binding protein A10 (calpactin) |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of S100A10 protein |
CTD |
PMID:30545405 |
|
NCBI chr 3:93,462,424...93,471,952
Ensembl chr 3:93,462,387...93,471,950
|
|
G |
S100a11 |
S100 calcium binding protein A11 |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of S100A11 protein |
CTD |
PMID:30545405 |
|
NCBI chr 3:93,427,803...93,433,595
Ensembl chr 3:93,427,795...93,433,594
|
|
G |
Scarb2 |
scavenger receptor class B, member 2 |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of SCARB2 protein |
CTD |
PMID:30545405 |
|
NCBI chr 5:92,589,170...92,653,516
Ensembl chr 5:92,589,173...92,654,692
|
|
G |
Serpinb6a |
serine (or cysteine) peptidase inhibitor, clade B, member 6a |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of SERPINB6 protein |
CTD |
PMID:30545405 |
|
NCBI chr13:34,101,901...34,186,777
Ensembl chr13:34,101,901...34,186,777
|
|
G |
Shmt2 |
serine hydroxymethyltransferase 2 (mitochondrial) |
decreases expression multiple interactions |
EXP ISO |
Neomycin results in decreased expression of SHMT2 mRNA [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of SHMT2 protein |
CTD |
PMID:30545405 PMID:30626089 |
|
NCBI chr10:127,352,992...127,358,313
Ensembl chr10:127,352,992...127,358,313
|
|
G |
Slc10a1 |
solute carrier family 10 (sodium/bile acid cotransporter family), member 1 |
multiple interactions |
EXP |
[Cephalothin co-treated with Neomycin] results in increased expression of SLC10A1 mRNA |
CTD |
PMID:24657338 |
|
NCBI chr12:80,999,959...81,015,479
Ensembl chr12:80,999,957...81,015,479
|
|
G |
Slc22a7 |
solute carrier family 22 (organic anion transporter), member 7 |
multiple interactions |
EXP |
[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of SLC22A7 mRNA |
CTD |
PMID:36464106 |
|
NCBI chr17:46,743,111...46,749,403
Ensembl chr17:46,743,109...46,749,383
|
|
G |
Slc3a1 |
solute carrier family 3, member 1 |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of SLC3A1 protein |
CTD |
PMID:30545405 |
|
NCBI chr17:85,335,775...85,371,669
Ensembl chr17:85,335,804...85,371,664
|
|
G |
Slc51b |
solute carrier family 51, beta subunit |
multiple interactions |
EXP |
[Cephalothin co-treated with Neomycin] results in decreased expression of SLC51B mRNA |
CTD |
PMID:24657338 |
|
NCBI chr 9:65,320,035...65,330,055
Ensembl chr 9:65,319,996...65,330,237
|
|
G |
Slco1b2 |
solute carrier organic anion transporter family, member 1b2 |
multiple interactions |
EXP |
[Cephalothin co-treated with Neomycin] results in increased expression of SLCO1B2 mRNA |
CTD |
PMID:24657338 |
|
NCBI chr 6:141,575,178...141,632,372
Ensembl chr 6:141,575,244...141,632,372
|
|
G |
Smad6 |
SMAD family member 6 |
increases expression |
EXP |
Neomycin results in increased expression of SMAD6 mRNA |
CTD |
PMID:30626089 |
|
NCBI chr 9:63,860,358...63,929,374
Ensembl chr 9:63,860,358...63,929,341
|
|
G |
Smad9 |
SMAD family member 9 |
increases expression |
EXP |
Neomycin results in increased expression of SMAD9 mRNA |
CTD |
PMID:30626089 |
|
NCBI chr 3:54,662,873...54,709,162
Ensembl chr 3:54,663,003...54,708,678
|
|
G |
Smpd2 |
sphingomyelin phosphodiesterase 2, neutral |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of SMPD2 protein |
CTD |
PMID:30545405 |
|
NCBI chr10:41,363,168...41,366,410
Ensembl chr10:41,361,638...41,366,365
|
|
G |
Sqle |
squalene epoxidase |
multiple interactions |
EXP |
[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of SQLE mRNA |
CTD |
PMID:36464106 |
|
NCBI chr15:59,186,941...59,203,042
Ensembl chr15:59,186,926...59,203,041
|
|
G |
Sqstm1 |
sequestosome 1 |
multiple interactions |
EXP |
[Vancomycin co-treated with Neomycin co-treated with Metronidazole] promotes the reaction [Zinc Oxide analog results in increased expression of SQSTM1 protein] |
CTD |
PMID:36535435 |
|
NCBI chr11:50,090,979...50,105,303
Ensembl chr11:50,090,193...50,101,654
|
|
G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
multiple interactions |
EXP |
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of SREBF1 mRNA]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of SREBF1 mRNA |
CTD |
PMID:36464106 |
|
NCBI chr11:60,089,910...60,113,407
Ensembl chr11:60,089,915...60,113,407
|
|
G |
Srebf2 |
sterol regulatory element binding factor 2 |
multiple interactions |
EXP |
[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of SREBF2 mRNA |
CTD |
PMID:36464106 |
|
NCBI chr15:82,031,455...82,089,580
Ensembl chr15:82,031,382...82,089,580
|
|
G |
Sst |
somatostatin |
multiple interactions |
EXP |
[Vancomycin co-treated with Neomycin co-treated with Metronidazole] promotes the reaction [Zinc Oxide results in increased expression of SST mRNA]; [Vancomycin co-treated with Neomycin co-treated with Metronidazole] results in increased expression of SST mRNA |
CTD |
PMID:36535435 |
|
NCBI chr16:23,708,327...23,710,041
Ensembl chr16:23,708,323...23,709,708
|
|
G |
Sstr2 |
somatostatin receptor 2 |
multiple interactions |
EXP |
[Vancomycin co-treated with Neomycin co-treated with Metronidazole] promotes the reaction [Zinc Oxide results in increased expression of SSTR2 mRNA] |
CTD |
PMID:36535435 |
|
NCBI chr11:113,510,153...113,516,854
Ensembl chr11:113,510,168...113,516,854
|
|
G |
Tars1 |
threonyl-tRNA synthetase 1 |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TARS1 protein |
CTD |
PMID:30545405 |
|
NCBI chr15:11,383,749...11,399,744
Ensembl chr15:11,382,387...11,399,751
|
|
G |
Tgfb2 |
transforming growth factor, beta 2 |
multiple interactions increases expression |
EXP |
Plant Oils inhibits the reaction [Neomycin results in increased expression of TGFB2 mRNA] |
CTD |
PMID:30626089 |
|
NCBI chr 1:186,354,984...186,441,504
Ensembl chr 1:186,354,989...186,438,186
|
|
G |
Tjp1 |
tight junction protein 1 |
multiple interactions |
EXP |
[Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of TJP1 mRNA]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of TJP1 protein] |
CTD |
PMID:35390362 |
|
NCBI chr 7:64,945,913...65,177,629
Ensembl chr 7:64,945,913...65,177,529
|
|
G |
Tlr4 |
toll-like receptor 4 |
multiple interactions |
EXP |
[Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of TLR4 mRNA]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of TLR4 protein]; TLR4 gene mutant form results in decreased susceptibility to [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] |
CTD |
PMID:35390362 |
|
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
|
|
G |
Tm9sf2 |
transmembrane 9 superfamily member 2 |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TM9SF2 protein |
CTD |
PMID:30545405 |
|
NCBI chr14:122,342,290...122,397,015
Ensembl chr14:122,344,450...122,397,016
|
|
G |
Tmed10 |
transmembrane p24 trafficking protein 10 |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TMED10 protein |
CTD |
PMID:30545405 |
|
NCBI chr12:85,387,388...85,421,491
Ensembl chr12:85,387,388...85,421,621
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
EXP |
[Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; [Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] results in decreased expression of TNF protein; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of and results in increased secretion of TNF protein]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of TNF mRNA]; [Vancomycin co-treated with Neomycin co-treated with Cilastatin, Imipenem Drug Combination] inhibits the reaction [Doxorubicin results in increased expression of TNF protein]; [Vancomycin co-treated with Neomycin co-treated with Cilastatin, Imipenem Drug Combination] inhibits the reaction [Nanotubes, Carbon promotes the reaction [Doxorubicin results in increased expression of TNF protein]]; Dextran Sulfate inhibits the reaction [[Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] results in decreased expression of TNF protein] |
CTD |
PMID:31442584 PMID:32068018 PMID:35390362 |
|
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
|
|
G |
Traf6 |
TNF receptor-associated factor 6 |
multiple interactions |
EXP |
[Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of TRAF6 mRNA]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of TRAF6 protein] |
CTD |
PMID:35390362 |
|
NCBI chr 2:101,508,765...101,532,013
Ensembl chr 2:101,508,774...101,532,014
|
|
G |
Tubal3 |
tubulin, alpha-like 3 |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TUBAL3 protein |
CTD |
PMID:30545405 |
|
NCBI chr13:3,974,695...3,985,277
Ensembl chr13:3,968,274...3,985,277
|
|
G |
Twf1 |
twinfilin actin binding protein 1 |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TWF1 protein |
CTD |
PMID:30545405 |
|
NCBI chr15:94,475,829...94,487,727
Ensembl chr15:94,475,832...94,487,770
|
|
G |
Txn1 |
thioredoxin 1 |
multiple interactions |
EXP |
[Vancomycin co-treated with Neomycin co-treated with Metronidazole] promotes the reaction [Zinc Oxide analog results in increased expression of TXN1 protein] |
CTD |
PMID:36535435 |
|
NCBI chr 4:57,943,373...57,956,411
Ensembl chr 4:57,943,373...57,956,411
|
|
G |
Txndc5 |
thioredoxin domain containing 5 |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TXNDC5 protein |
CTD |
PMID:30545405 |
|
NCBI chr13:38,684,242...38,712,800
Ensembl chr13:38,684,055...38,712,800
|
|
G |
Uqcrc1 |
ubiquinol-cytochrome c reductase core protein 1 |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of UQCRC1 protein |
CTD |
PMID:30545405 |
|
NCBI chr 9:108,765,716...108,778,709
Ensembl chr 9:108,765,701...108,778,691
|
|
G |
Uqcrfs1 |
ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of UQCRFS1 protein |
CTD |
PMID:30545405 |
|
NCBI chr13:30,724,295...30,729,299
Ensembl chr13:30,724,291...30,729,345
|
|
G |
Uqcrh |
ubiquinol-cytochrome c reductase hinge protein |
multiple interactions |
ISO |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of UQCRH protein |
CTD |
PMID:30545405 |
|
NCBI chr 4:115,924,162...115,932,267
Ensembl chr 4:115,924,162...115,932,268
|
|
G |
Vdr |
vitamin D (1,25-dihydroxyvitamin D3) receptor |
multiple interactions |
EXP |
[Cephalothin co-treated with Neomycin] results in increased expression of VDR mRNA |
CTD |
PMID:24657338 |
|
NCBI chr15:97,752,308...97,806,177
Ensembl chr15:97,752,306...97,808,511
|
|